Angina/Coronary Heart Disease

Coronary heart disease (CHD) is a significant cause of mortality and disability. Regular physical activity plays a crucial role in maintaining the health of the heart muscle, preserving vessel elasticity, reducing blood pressure, and enhancing physical balance and strength. It forms the foundation of chronic disease management programs and rehabilitation plans for cardiac or stroke patients, aiding in improved mobility, flexibility, and muscle strengthening. Our regenerative therapy aims to effectively regenerate damaged heart tissue.

Mesenchymal stem cells (MSCs) are a type of cells that can be obtained from various human tissues. They possess multipotent and immunomodulatory characteristics that aid in tissue repair and help prevent immune responses. Extensive research has demonstrated the feasibility, safety, and efficacy of MSC-based therapy for cardiovascular diseases. Although the precise mechanisms of MSCs are not fully understood, their therapeutic potential in treating ischemic diseases has been investigated in phase I/II clinical trials. MSCs hold promise as an effective therapeutic strategy for both ischemic and non-ischemic cardiovascular disorders.

Angina Coronary Heart Disease

You may also be interested

Citations and Scientific References

Our medical unit is highly esteemed for partnering globally with fellow researchers on scientific studies and contributing to respected scientific journals.

View References